These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2992857)

  • 1. Characterization of Epstein-Barr virus-specific T-cell hybridomas derived from infectious mononucleosis.
    Valentine MA; Tsoukas CD; Vaughan JH; Carson DA
    Clin Immunol Immunopathol; 1985 Oct; 37(1):56-62. PubMed ID: 2992857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of monoclonal antibodies against lymphocyte surface antigens on interleukin 2 excretion by Epstein-Barr virus-specific human T-cell hybridomas.
    Lakow ES; Valentine MA; Vaughan JH; Tsoukas CD; Carson DA
    Cell Immunol; 1984 Apr; 85(1):67-74. PubMed ID: 6325024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
    J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8+ T cell subsets of cytotoxic T lymphocytes induced by Epstein-Barr virus infection in infectious mononucleosis.
    Ebihara T; Sakai N; Koyama S
    Tohoku J Exp Med; 1990 Nov; 162(3):213-24. PubMed ID: 1965352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
    Enssle KH; Fleischer B
    Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level.
    Lipinski M; Fridman WH; Tursz T; Vincent C; Pious D; Fellous M
    J Exp Med; 1979 Dec; 150(6):1310-22. PubMed ID: 229186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biology of circulating B lymphocytes infected with Epstein-Barr virus during infectious mononucleosis.
    Robinson JE
    Yale J Biol Med; 1982; 55(3-4):311-6. PubMed ID: 6295008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells.
    Niedobitek G; Agathanggelou A; Herbst H; Whitehead L; Wright DH; Young LS
    J Pathol; 1997 Jun; 182(2):151-9. PubMed ID: 9274524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive T cells in the immune repertoire: self-restricted and allo-restricted helper T-cell clones to Epstein-Barr virus.
    Lai PK; Pauza ME; Switzer BL; Smith D; Purtilo DT
    Int J Cancer; 1987 Jan; 39(1):111-7. PubMed ID: 3025108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis.
    Robinson J; Smith D; Niederman J
    Nature; 1980 Sep; 287(5780):334-5. PubMed ID: 6252472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T lymphocytes in infectious mononucleosis; effect of IL-2 on the outgrowth of Epstein-Barr virus-infected cells.
    Misko IS; Burrows SR; Schmidt C; Bishop CJ; Ryan JM; Staples JA; Moss DJ
    Immunol Cell Biol; 1989 Feb; 67 ( Pt 1)():49-55. PubMed ID: 2785955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Epstein-Barr virus-associated superantigen.
    Sutkowski N; Palkama T; Ciurli C; Sekaly RP; Thorley-Lawson DA; Huber BT
    J Exp Med; 1996 Sep; 184(3):971-80. PubMed ID: 9064357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus increases the proliferative response and the generation of suppressor and cytotoxic T-cell functions in autologous mixed lymphocyte reaction.
    Palacios R
    Scand J Immunol; 1982 Jan; 15(1):17-24. PubMed ID: 6280268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic cell death of primed CD45RO+ T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis.
    Uehara T; Miyawaki T; Ohta K; Tamaru Y; Yokoi T; Nakamura S; Taniguchi N
    Blood; 1992 Jul; 80(2):452-8. PubMed ID: 1320953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G; Rickinson AB
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
    Strang G; Rickinson AB
    Immunology; 1987 Dec; 62(4):647-54. PubMed ID: 2828228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells.
    Gallagher G; Stimson WH
    Immunology; 1984 Dec; 53(4):611-21. PubMed ID: 6209205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Epstein-Barr virus in lymphoid tissues of patients with infectious mononucleosis by in situ hybridization.
    Prange E; Trautmann JC; Kreipe H; Radzun HJ; Parwaresch MR
    J Pathol; 1992 Feb; 166(2):113-9. PubMed ID: 1313863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
    Tosato G; Straus S; Henle W; Pike SE; Blaese RM
    J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
    Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T
    J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.